Supply Chain Intelligence

Compass Therapeutics, Inc. Supply Chain

CMPX supply chain intelligence for Compass Therapeutics, Inc.: verified suppliers, customers, debt relationships, acquisitions, and ownership data.

CMPX ·Last updated 2026-07-30 · Interactive map →

Data compiled by Redley Lamar · ChainSifter Intelligence

5Suppliers
1Customers
2Debt Items
7Related Chains

Compass Therapeutics, Inc. Suppliers

TickerNameConfidenceEvidence
ABL-BIO-INC ABL-BIO-INC 92% We have licensed exclusive global rights to tovecimig, outside of South Korea, from ABL Bio, Inc.
ELPISCIENCE-BIOPHARMACEUTICALS-CO-LIMITED ELPISCIENCE-BIOPHARMACEUTICALS-CO-LIMITED 92% China rights were out-licensed from us to Elpiscience Biopharmaceuticals Co., Limited
HANDOK-PHARMACEUTICALS-INC HANDOK-PHARMACEUTICALS-INC 92% South Korean rights are held by Handok Pharmaceuticals, Inc.
ABL-BIO ABL-BIO 90% ABL Bio received a $5 million upfront payment and a $6 million milestone payment
ADIMAB-LLC ADIMAB-LLC 90% We are required to make payments upon achievement of development milestones that, as of December 31, 2025, amounted to $3.5 million

Compass Therapeutics, Inc. Customers

TickerNameConfidenceEvidence
TRIGR-THERAPEUTICS-INC TRIGR-THERAPEUTICS-INC 62% dustry including, but not limited to: having a limited operating history and no products approved for commercial sale; having a history of significant losses; its need to obtain additional financing;…

Compass Therapeutics, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
CMPX-DEBT-8725 Xbrl Convertible 90% xbrl convertible detail from xbrl 2020-12-31.
CMPX-DEBT Debt stack $9.8M 90% Market cache reports total debt of $9.8M.

Compass Therapeutics, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Compass Therapeutics, Inc..

Compass Therapeutics, Inc. Ownership

HolderNameConfidenceEvidence
CMPX-OWNER-TANG-CAPITAL-MANAGEMENT-LLC Tang Capital Management, LLC 90% 13F overlay lists Tang Capital Management, LLC as top holder; 10 tracked holders.

Compass Therapeutics, Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
SNYNF Sanofi 100.00 2
BNTX BioNTech SE 100.00 2
SMMT Summit Therapeutics Inc. 100.00 2
CMOS CMOS 50.00 2
CROS CROS 50.00 2
CBIO Crescent Biopharma, Inc. 36.29 1 ['spend']
KELUN KELUN 23.09 2
View CMPX supply chain intel →

Explore the full interactive supply chain map for Compass Therapeutics, Inc..

Open CMPX supply chain map →
ChainSifter · Guerilla Finance Terms Disclaimer ← Back to Map